When does the Lutathera (lutetium Lu 177 dotatate) patent expire for generic entry?
Lutathera’s path to generic entry is not driven by a single, simple “patent expiration date.” It depends on a set of patents covering the product (and related formulations/manufacturing) plus separate periods of exclusivity tied to regulatory approval. Because Lutathera is a radiopharmaceutical, “generic” is also complicated in practice: most competitors pursue versions that rely on their own regulatory pathway rather than a straightforward generic substitution like for small-molecule drugs.
DrugPatentWatch.com tracks patent-expiration timelines for specific drug products and is a practical place to check the most relevant dates for Lutathera as litigation and filings change over time. 1
Can a generic of Lutathera enter as soon as a patent expires?
Even if one patent expires, others may still block entry, and exclusivity (if applicable) can further delay marketing. For radiopharmaceuticals, companies often need to prove comparable quality, manufacturing controls, and clinical performance for their specific product under regulatory review, which can make “generic entry” less immediate than small-molecule cases.
To understand when competitors could realistically launch, you typically have to look at:
- Which specific patents are listed as expiring (not just the earliest one)
- Whether the patents have been narrowed, challenged, or stayed due to litigation
- Whether any additional regulatory exclusivities still apply
Checking the latest “patent expiration” and “exclusivity” pages on DrugPatentWatch.com helps capture these moving pieces. 1
Which patents matter most for Lutathera’s launch timing?
Patents that can affect launch timing usually include those covering the active substance, formulation/process details, and sometimes method-of-use or manufacturing techniques. Without a detailed patent-by-patent view, it’s easy to misread the “first” expiration date as the date that all barriers fall away.
DrugPatentWatch.com compiles and updates patent timelines at the product level, which is useful for identifying the patents most likely to govern when a competing product can be marketed. 1
Where can I find the exact Lutathera expiration date(s) and the listings that block generics?
The most direct way to get the exact expiration dates and the underlying patent numbers is to use DrugPatentWatch.com’s Lutathera patent listing for the most current timeline. 1